“…pN1b does not independently affect the cause specific survival of patients (Ito et al, 2007), as a results, prophylactic lateral neck dissection was not recomanded (Doherty et al, 2009), this is also applied to level V. when study population was restricted to patients without a clinically evident level V lymph node, pN1b were present in a number of level V specimens (16-20%) (Roh et al, 2008), Noguchi reported that at least 75% of patients with PTC have occult lymph node metastases, but only about 20% become clinically evident, which means pN1b occasionally developed to be evident (Noguchi et al,1987). Carton reported a recurrence rate of 3% at level V, and they thought that recurrence rarely recurred at level V regardless of whether this lymphatic region had previously been found to be positive for metastatic disease, negative for metastatic disease or simply not dissected (Caron et al, 2006). In our study, 2 patients have shown recurrence to the lymph node,and just one patient showed nodal recurrence in ipsilateral level V. hence, patients with a clinically negative level V lymph node and occult lymph node metastases would be expected to have lower recurrence rate.…”